Xylem Inc. (NYSE:XYL) – Equities researchers at Boenning Scattergood boosted their FY2017 EPS estimates for shares of Xylem in a research report issued to clients and investors on Tuesday, Zacks Investment Research reports. Boenning Scattergood analyst R. Connors now anticipates that the industrial products company will earn $2.29 per share for the year, up from their prior estimate of $2.27. Boenning Scattergood has a “Outperform” rating on the stock. Boenning Scattergood also issued estimates for Xylem’s Q1 2018 earnings at $0.45 EPS and Q3 2018 earnings at $0.75 EPS.
Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.01. The firm had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.18 billion. Xylem had a net margin of 6.85% and a return on equity of 17.74%. The business’s revenue was up 33.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.54 EPS.
COPYRIGHT VIOLATION WARNING: “Xylem Inc. (XYL) Expected to Earn FY2017 Earnings of $2.29 Per Share” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://ledgergazette.com/2017/11/13/boenning-scattergood-research-analysts-boost-earnings-estimates-for-xylem-inc-xyl.html.
Other analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of Xylem from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Thursday, October 5th. Oppenheimer Holdings, Inc. restated a “buy” rating and set a $66.00 target price (up from $60.00) on shares of Xylem in a research report on Tuesday, August 1st. Cowen and Company restated a “buy” rating and set a $70.00 target price on shares of Xylem in a research report on Thursday, September 21st. Seaport Global Securities reissued a “buy” rating on shares of Xylem in a research report on Wednesday, November 1st. Finally, Canaccord Genuity reissued a “hold” rating and issued a $56.00 price objective on shares of Xylem in a research report on Friday, October 6th. Six analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $65.17.
Shares of Xylem (NYSE XYL) opened at $66.25 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.88. The stock has a market cap of $11,898.50, a PE ratio of 28.93, a PEG ratio of 1.85 and a beta of 1.16. Xylem has a 1 year low of $46.67 and a 1 year high of $67.64.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Thursday, November 2nd will be paid a $0.18 dividend. The ex-dividend date is Wednesday, November 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.09%. Xylem’s dividend payout ratio is currently 41.86%.
In other Xylem news, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total value of $2,505,386.70. Following the transaction, the insider now directly owns 61,979 shares in the company, valued at approximately $4,078,837.99. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $66.25, for a total transaction of $2,497,625.00. Following the completion of the transaction, the director now owns 58,831 shares in the company, valued at $3,897,553.75. The disclosure for this sale can be found here. 0.75% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in XYL. USS Investment Management Ltd bought a new position in shares of Xylem during the second quarter valued at approximately $91,840,000. Janus Henderson Group PLC boosted its stake in shares of Xylem by 404.5% during the second quarter. Janus Henderson Group PLC now owns 1,853,943 shares of the industrial products company’s stock valued at $102,758,000 after purchasing an additional 1,486,463 shares in the last quarter. Voya Investment Management LLC boosted its stake in shares of Xylem by 554.0% during the second quarter. Voya Investment Management LLC now owns 1,242,748 shares of the industrial products company’s stock valued at $68,886,000 after purchasing an additional 1,052,719 shares in the last quarter. William Blair Investment Management LLC bought a new position in shares of Xylem during the second quarter valued at approximately $48,151,000. Finally, State Street Corp boosted its stake in shares of Xylem by 11.5% during the second quarter. State Street Corp now owns 8,360,506 shares of the industrial products company’s stock valued at $460,211,000 after purchasing an additional 861,484 shares in the last quarter. Hedge funds and other institutional investors own 86.14% of the company’s stock.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.